.png){kind=icon}
.png){kind=icon}
Return
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology
.png){kind=icon}
OA
AI
F
F
G
F
M
S
P
P
M
E
L
L
S
E
G
G
A
M
M
A
DOI：10.1016/j.dld.2026.05.004.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Advanced therapies (ADTs) have transformed the management of chronic immune-mediated inflammatory diseases (IMIDs) across gastroenterology, dermatology, and rheumatology. Their growing use pressures universal, regionalized systems such as the Italian National Health System, challenging sustainability, equitable access, and integration of innovation. To address these challenges, an interdisciplinary Italian consortium (Latium Net) developed consensus-based recommendations on sustainability and innovation in IMIDs care.
Keywords:
Biosimilar
Cost-effectiveness
Health care sustainability
Patient-reported outcomes
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.8
Papers:
1.2W
Citations:
8.7K
Organization
No organization information available
Cited Papers